News

Structural model of the active site of procaspase-3

Wells uses small molecules to trigger cell death

Wed Dec 16, 2009

Research directed by senior author James Wells, PhD, chair of the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, has opened the door to a new way of studying and better understanding the processes of cell death (apoptosis), blood clotting, and other biochemical pathways. Insights could lead to the development...

Method to predict polypharmacology developed in Shoichet Lab

Tue Dec 15, 2009

A computational method developed in the UCSF School of Pharmacy under the direction of faculty member Brian Shoichet, PhD, has the potential to predict new target diseases for existing drugs as well as unexpected side effects of approved drugs.

While the development of a specific drug to affect a specific disease...

California Poison Control System receives funding through June 2010

Fri Dec 11, 2009

The University of California, San Francisco-operated California Poison Control System (CPCS), which had already sent layoff notices to its employees January 15, 2010, has secured funding to rescind the notices and continue to care for Californians, through June 2010, via its free and immediate 24 hour per day, 7 days per week advice and...

TIRF imaging shows highly localized YFP recruitment.

UCSF innovation among top 10 for 2009

Mon Dec 7, 2009

The Scientist has cited a UCSF innovation among its top 10 list of tools to hit the life sciences in 2009. In the spotlight is a paper that reveals how to import plant "light switches" into mammalian cells to control complex regulatory processes. The paper appeared in the October 15, 2009 issue of Nature. Authors are the UCSF...

Lipton argues for pharmacists in the medical home

Mon Dec 7, 2009

Helene Levens Lipton, PhD, faculty member in the UCSF School of Pharmacy, presents data in support of including pharmacists in the medical home model of health care. Her editorial appears in the November 23, 2009 issue of the Archives of Internal Medicine.

Press Release: Team-Based Care and Medical Homes May...

Craik to lead Takeda-sponsored research on antibodies

Mon Nov 2, 2009

Takeda San Francisco, Inc., announced September 21, 2009 that it has entered into a sponsored collaboration with UCSF to support antibody-related research in the laboratory of Charles S. Craik, PhD, faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy. Craik will be the...

Kroetz discusses pharmacogenomics on KQED Quest radio

Fri Oct 16, 2009

UCSF researcher Deanna Kroetz, PhD, discusses the impact of genetic differences on how an individual responds to drugs in a KQED Quest radio interview that aired September 14, 2009. Fellow members of the interview panel were UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, and UCSF breast cancer surgeon...

Study identifies lack of information about HER2 testing practices

Fri Oct 16, 2009

Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of HER2, trastuzumab can be highly effective. These...

UCSF researchers join consortium to target cancer in new ways

Thu Oct 15, 2009

Scientists from the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry have been selected to lead a new federal initiative aimed at developing new classes of drugs to target cancer.

According to the National Cancer Institute (NCI), "To advance the NCI's mission of bringing novel therapies to patients, and to fully exploit...